Global Community

Vertiv stumbles on earnings day even after strong growth and a higher outlook, suggesting the stock price may be driven more by hype and forced buying than by the business itself. The key question now is whether the selloff actually makes it a good deal—or just a less expensive version of an already pricey favorite.Read more

A little-known ride-hailing company in Türkiye claims its market looks like the early days of ride apps in the U.S., with lots of room to grow and raise prices over time. It also says it has a clearer path to profits and fewer cost headaches than big U.S. platforms, while expanding from rides into deliveries and other everyday services.Read more

MindWalk Holdings is no longer just a lab-for-hire business—it’s shifting into software that helps drug teams learn from biology data, and the market may not be treating it that way yet. The story hinges on whether its LensAI platform keeps landing sticky enterprise customers and whether its drug programs attract partners without forcing shareholders to fund the bill.Read more

Macnica’s chip-trading business keeps growing thanks to strong demand linked to AI and overseas customers, but its push into autonomous driving is taking longer to turn pilots into real deployments. See what this mix of steady core demand and a delayed new growth engine could mean for profits and the company’s outlook.Read more

Robo.ai puts a former international police chief in charge of a new Abu Dhabi-based unit aimed at building secure AI systems for governments and critical infrastructure. The move signals a push into high-stakes public-sector work where trust, safety, and compliance can make or break growth.Read more

Pagaya is moving from a tough period of high interest rates into a friendlier backdrop, and the business is already turning profitable. As borrowing gets cheaper and more banks plug into its approval technology, loan activity could pick up—though the story depends on rates falling and partners continuing to lean on its network.Read more

After a sharp sell-off, PROCEPT BioRobotics may be getting punished more for shifting how it reports sales than for any real slowdown in what doctors are doing. The bigger question is whether a feared medical procedure trend is actually a non-issue, and if upcoming results can reset sentiment.Read more

Hims & Hers grows from a telehealth brand into a broader online healthcare service that spans everything from primary care to mental health and weight management. The big question is whether it can keep growing while handling changing rules around popular weight-loss treatments and rising competition from much larger players.Read more

Charter’s biggest build-out is close to finishing, and that could leave the business throwing off a lot more cash even if customer growth stays weak. The story hinges on debt being cheaper to buy back than people think, plus potential cost cuts and an outside partnership rumor that could change the market’s mood.Read more